All In Biotech

Drug Trial Radar · NCT05937178

Real-world Study Optimizing Nucleotide-analogues

A Real-world Study of Optimizing Nucleotide-analogues-based Treatment for Chronic Hepatitis B

Last checked: Nov 19, 2026Latest source record: Jul 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20,000

Planned (sponsor's estimate)

Start

Jan 31, 2023

Primary completion

Jan 31, 2029

Study completion Jan 31, 2029

Sponsor

Lead sponsor
Huashan HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The First Affiliated Hospital of Anhui Medical University; Anhui Provincial Hospital; Beijing YouAn Hospital; Peking University People's Hospital; Peking University First Hospital; Xiamen Hospital of Traditional Chinese Medicine; First Affiliated Hospital of Fujian Medical University; LanZhou University; Third Affiliated Hospital, Sun Yat-Sen University; First Affiliated Hospital of Guangxi Medical University; The Affiliated Hospital Of Guizhou Medical University; Hainan General Hospital; Hebei Medical University Third Hospital; The First Affiliated Hospital of Henan University of Traditional Chinese Medicine; Henan Provincial People's Hospital; The Second Affiliated Hospital of Harbin Medical University; Tongji Hospital; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Renmin Hospital of Wuhan University; Central South University; Xiangya Hospital of Central South University; The First Hospital of Jilin University; the Second Hospital of Nangjing; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; The First Affiliated Hospital with Nanjing Medical University; The Affiliated Hospital of Xuzhou Medical University; The First Affiliated Hospital of Nanchang University; Shengjing Hospital; Qingdao Sixth People's Hospital; Shandong Provincial Hospital; The Second Hospital of Shandong University; The First Affiliated Hospital of Shanxi Medical University; Tang-Du Hospital; First Affiliated Hospital Xi'an Jiaotong University; Ruijin Hospital; West China Hospital; Tianjin Second People's Hospital; First Affiliated Hospital of Xinjiang Medical University; The First People's Hospital of Yunnan; Shulan (Hangzhou) Hospital; Zhejiang University; Southwest Hospital, China; The Second Affiliated Hospital of Chongqing Medical University; Sichuan Provincial People's Hospital
First posted
Jul 10, 2023

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this multicenter, observational, prospective study is to observe and compare different anti-viral treatment strategies in a real-world cohort of patients with CHB managed in routine clinical settings in China. The main questions it aims to answer are: 1. To evaluate the benefits of initiating first-line nucleos(t)ide analogue in patients with chronic HBV infection who are recommended in the updated Chinese Guideline 2022, but not recommended in the Chinese Guideline 2019. 2. To evaluate the Chinese Guideline recommends initiation of treatment, but at least one foreign authoritative guideline (eg. AASLD, EASL) does not recommend the benefit of initiating first-line nucleos(t)ide analogue in patients with chronic HBV infection who initiate treatment. 3. To compare the treatment effect of different alternatives with patients who have partial response after treatment with first-line nucleos(t)ide analogues.

Conditions

  • Hepatitis B, Chronic

Interventions

  • ETV/TAF/TDF/TMF/IFNDrug

    peginterferon alpha or nucleos(t)ide alone are decided by patients' doctors according to their conditions, instead of extra interventions brought by the study

  • ETV/TAF/TDF/TMFDrug

    peginterferon alpha or nucleos(t)ide alone are decided by patients' doctors according to their conditions, instead of extra interventions brought by the study

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of patients with HBV DNA <20 IU/mlTime frame: Week 48
  2. The proportion of patients with HBV DNA <20 IU/mlTime frame: Week 96
  3. The proportion of patients with HBV DNA <20 IU/mlTime frame: Week 144
  4. Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Baseline
  5. Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Week 48
  6. Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Week 96
  7. Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Week 144

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • Huashan Hospital

    Shanghai, China · Recruiting

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Not yet recruiting

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Not yet recruiting

  • Beijing YouAn Hospita

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • the Southwest Hospital of AMU

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Not yet recruiting

  • Xiamen Hospital of Traditional Chinese Medicine

    Xiamen, Fujian, China · Not yet recruiting

  • the First Hospital of Lanzhou University

    Lanzhou, Gansu, China · Not yet recruiting

  • First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Not yet recruiting

  • The Affiliated Hospital Of Guizhou Medical University

    Guiyang, Guizhou, China · Not yet recruiting

  • The Second Affiliated Hospital of Harbin Medical University

    Ha’erbin, Ha'erbin, China · Not yet recruiting

  • Hainan General Hospital

    Haikou, Hainan, China · Not yet recruiting

  • the Third Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Not yet recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

    Zhengzhou, Henan, China · Not yet recruiting

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China · Not yet recruiting

  • Tongji Hospital

    Wuhan, Hubei, China · Not yet recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • the Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • Xiangya Hospital Central South University

    Changsha, Hunan, China · Not yet recruiting

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    Nanjing, Jiangsu, China · Not yet recruiting

  • the Second Hospital of Nangjing

    Nanjing, Jiangsu, China · Not yet recruiting

  • the Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China · Recruiting

  • the First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Not yet recruiting

  • the First Bethune Hospital Of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China · Not yet recruiting

  • Tangdu Hospital, The Fourth Military Medical University

    Xi'an, Shaanxi, China · Not yet recruiting

  • the First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China · Not yet recruiting

  • Shandong Provincial Hospital Affiliated to Shandong First Medical University

    Jinan, Shandong, China · Not yet recruiting

  • The Second Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • No. 6 People's Hospital of Qingdao

    Qingdao, Shandong, China · Not yet recruiting

  • Ruijin Hospital

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China · Not yet recruiting

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China · Not yet recruiting

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China · Not yet recruiting

  • Tianjin Second People's Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.